National Health Investors, Inc. (NYSE:NHI) Director Robert A. Mccabe, Jr. Buys 437 Shares

National Health Investors, Inc. (NYSE:NHI) Director Robert A. Mccabe, Jr. bought 437 shares of the firm’s stock in a transaction dated Friday, May 31st. The shares were acquired at an average price of $65.83 per share, for a total transaction of $28,767.71. Following the acquisition, the director now directly owns 21,585 shares of the company’s stock, valued at approximately $1,420,940.55. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

National Health Investors Stock Performance

NHI opened at $66.08 on Friday. The business has a fifty day simple moving average of $63.03 and a 200 day simple moving average of $58.28. The company has a market capitalization of $2.87 billion, a PE ratio of 21.66 and a beta of 0.95. National Health Investors, Inc. has a 1 year low of $48.51 and a 1 year high of $67.45. The company has a debt-to-equity ratio of 0.91, a current ratio of 13.24 and a quick ratio of 13.24.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be issued a $0.90 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.60 annualized dividend and a yield of 5.45%. National Health Investors’s dividend payout ratio is presently 118.03%.

Hedge Funds Weigh In On National Health Investors

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC raised its holdings in National Health Investors by 3,690.7% in the 4th quarter. International Assets Investment Management LLC now owns 28,430 shares of the real estate investment trust’s stock valued at $1,588,000 after acquiring an additional 27,680 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in National Health Investors by 4.6% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 189,221 shares of the real estate investment trust’s stock valued at $10,568,000 after acquiring an additional 8,316 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of National Health Investors by 8.5% during the 4th quarter. Principal Financial Group Inc. now owns 1,870,632 shares of the real estate investment trust’s stock worth $104,475,000 after buying an additional 146,735 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of National Health Investors by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 6,173,352 shares of the real estate investment trust’s stock worth $317,063,000 after buying an additional 22,443 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. raised its holdings in shares of National Health Investors by 14.4% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 30,971 shares of the real estate investment trust’s stock worth $1,730,000 after buying an additional 3,907 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

NHI has been the topic of several research analyst reports. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price on the stock in a report on Tuesday, March 12th. Wedbush raised their price target on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a report on Monday, March 18th. Truist Financial raised their price target on National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a report on Thursday, April 4th. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Finally, Wells Fargo & Company raised their price target on National Health Investors from $63.00 to $69.00 and gave the company an “overweight” rating in a report on Thursday. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $61.25.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.